Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2049-3002

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer ; volume:2 ; number:1 ; day:28 ; month:5 ; year:2014 ; pages:1 ; date:5.2014
Cancer & metabolism ; 2, Heft 1 (28.5.2014), 1, 5.2014

Creator: Imbert-Fernandez, Yoannis

Contributor: Telang, Sucheta
Chesney, Jason
SpringerLink (Online service)

DOI: 10.1186/2049-3002-2-S1-P29

URN: urn:nbn:de:1111-201605193933

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Imbert-Fernandez, Yoannis
Telang, Sucheta
Chesney, Jason
SpringerLink (Online service)

Other Objects (12)

Src kinase inhibition promotes the chondrocyte phenotype

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells

Estrogen modulates serotonin effects on vasoconstriction through Src inhibition

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor

Exosome markers of LRRK2 kinase inhibition

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase

The estrogen-gallstone connection: uncovering the pathways

Src kinase inhibition promotes the chondrocyte phenotype

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells

Estrogen modulates serotonin effects on vasoconstriction through Src inhibition

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor

Exosome markers of LRRK2 kinase inhibition

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase

The estrogen-gallstone connection: uncovering the pathways

Src kinase inhibition promotes the chondrocyte phenotype

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells

Estrogen modulates serotonin effects on vasoconstriction through Src inhibition

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor

Exosome markers of LRRK2 kinase inhibition

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase

The estrogen-gallstone connection: uncovering the pathways

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Src kinase inhibition promotes the chondrocyte phenotype

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells

Estrogen modulates serotonin effects on vasoconstriction through Src inhibition

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor

Exosome markers of LRRK2 kinase inhibition

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase

The estrogen-gallstone connection: uncovering the pathways

Src kinase inhibition promotes the chondrocyte phenotype

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells

Estrogen modulates serotonin effects on vasoconstriction through Src inhibition

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor

Exosome markers of LRRK2 kinase inhibition

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase

The estrogen-gallstone connection: uncovering the pathways

Src kinase inhibition promotes the chondrocyte phenotype

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells

Estrogen modulates serotonin effects on vasoconstriction through Src inhibition

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor

Exosome markers of LRRK2 kinase inhibition

The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy

The protein kinase CK2 catalytic domain from Plasmodium falciparum: crystal structure, tyrosine kinase activity and inhibition

Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase

The estrogen-gallstone connection: uncovering the pathways

Related objects

Reset password